skip to search skip to navigation skip to main content

Archive: Other activities

Suffering from ‘got to go now’ feeling – UroGuide launched to offer support to overactive bladder (OAB) patients

12th March 2017 in Other activities

UroGuide and OAB Awareness campaign has been launched to address lack of bladder disease awareness UroGuide is available for download from Lebanese Urology Society website  Failing to seek medical advice results in patients suffering unnecessarily with the burdens of OAB Beirut, 3rd March 2017. Lebanese Urology Society in partnership with Astellas Pharma have developed and…

Read Full Post

GenomeDx Announces Research Collaboration with Astellas to Identify Genomic Drivers of Patient Response to XTANDI® (enzalutamide) Capsules

13th February 2017 in Other activities

San Diego, January 2017 – Astellas in collaboration with GenomeDx Biosciences announced that it has entered into a research collaboration to apply genomic tumor profiling using GenomeDx’s Decipher® Classifier and Decipher GRID® as a potential aid in the identification of prostate cancer patients undergoing active surveillance who may benefit from treatment with XTANDI® (enzalutamide). As…

Read Full Post

Astellas Reports the First Nine Months Financial Results of FY2016

31st January 2017 in Other activities

Astellas Pharma Inc. (TOKYO: 4503) (President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced financial results for three quarters of fiscal year 2016 ending March 31, 2017 (“FY2016”). “We achieved many milestones including the acquisition of Ganymed Pharmaceuticals, a Germany-based pharma company, last December. The acquisition of Ganymed will enable Astellas to further expand its oncology…

Read Full Post

Prostate cancer mortality to incidence rate is five times greater in the MENA region than the USA1

13th March 2016 in Other activities

Astellas MENA/SSA hosts its annual Regional Oncology and Haematology Summit in Dubai Dubai, United Arab Emirates; 13 March 2016: During the Regional Oncology and Haematology Summit hosted by Astellas Middle East North & Sub Saharan Africa (MENA/SSA), a specialised briefing with regional patient groups and members of the press was held to discuss prostate cancer,…

Read Full Post

Astellas partners with CanSurvive to raise awareness on prostate cancer in Egypt on the occasion of World Cancer

04th February 2016 in Other activities

Cairo, Egypt; February 4, 2016: Marking World Cancer Day in Egypt, Astellas MENA/SSA has announced its partnership with  CanSurvive, Egypt’s leading groups for cancer patients in the country to raise awareness on prostate cancer.  The announcement has been made at  the Cancer from Patients’ Perspective (CPP) event, which is being held on the occasion of…

Read Full Post

MENA/SSA Headquarter Office Opening in Dubai

20th November 2014 in Other activities, Uncategorized

Chertsey, England and Dubai, UAE; 20th November, 2014: Astellas Pharma Europe Ltd., has announced the opening of a new regional office in Dubai to support the company’s growing business operations in the Middle East, North and Sub-Saharan Africa (MENA/SSA). Europe, the Middle East and Africa (EMEA) is an important territory for Astellas, contributing around one…

Read Full Post

Privacy Policy  |  Terms of Use  |  Cookies PolicyCopyright © 2019 Astellas Pharma